Surveillance of hospital admissions with respiratory tract infections in Norway - possibilities and hurdles
Creators
Description
This document outlines the necessity for developing a system for surveillance of hospital admissions
with laboratory-confirmed respiratory infections in Norway. Its basis is drawn from the learnings and
knowledge of the system (Beredt C19) that we established during the COVID-19 (Coronavirus disease
2019) pandemic and seeks to further describe the building blocks for a new system to be operated in
peacetime.
During the COVID-19 pandemic, using linked data sources for real-time monitoring of respiratory
infections played a vital role in producing timely knowledge to support decision making. Participating
in the Joint Action - Union and National Capacity Building 4 IntegraTED Surveillance
(UNITED4Surveillance) has given the Norwegian Institute of Public Health (NIPH), alongside the
Norwegian Directorate of Health, the opportunity to apply the insights gained from the pandemic.
The NIPH pilot focuses on planning and designing a concept for a surveillance system that utilizes
existing data sources to provide routine surveillance data for respiratory infections. The system aims
to be capable of scaling up in case of a crisis while ensuring legal and privacy aspects, addressing
infrastructure deficits, and identifying necessary data sources.
Norwegian data sources typically cover the entire population and can be linked through unique
personal identifiers. Those relevant for the surveillance system are identified and described in the
current report. By linking data from the hospital database (NPR), the laboratory database (MSIS) and
the population registry (FREG) the number of laboratory-confirmed hospital admissions, including
severity indicators and deaths can be supplied. With the addition of data on vaccinations (SYSVAK),
primary health care utilization (KPR) and medications (NorPD), the system can give important
information about vaccination status and medical risk factors, while the remaining four identified
registries (AA-register, SSB, NiPAR and CoDR) can give supplementary information e.g., in studies of
vaccine effectiveness.
Since January 1st, 2024, the NIPH has been data controller for the main health registers in Norway,
although the operational data controller responsibility is delegated to the different units within NIPH.
The legal framework concerning the processing of personal health data and coexistence between
relevant laws are discussed. Based on NIPH’s interpretation of the Personal Health Data Filing System
Act (“helseregisterloven”) §§ 19 – 19c, this is now considered the main legal basis to allow the
continuation of a SARI (severe acute respiratory infection) surveillance system. Routine surveillance in
peace time may be achieved by compiling health data from the health registries, producing
anonymous statistics to contribute to fulfilling the NIPH’s obligation for surveillance of communicable
diseases.
Additionally, technical challenges related to data timeliness, security, protocols, and necessary
resources are highlighted. It is important to build on the advantages that exist with current systems
in place and look to re-use parts or entire infrastructure, components, and solutions for future
development. In the case of this pilot, we have used the system of Beredt C19 as an illustration of
how data sharing was operated within NIPH during the COVID-19 pandemic.
This pilot forms the basic framework for the development of such a surveillance system, and the
recommendations will lay the groundwork for the implementation of the NORSURV Direct Grant (see
“definitions”) to make improvements to the Norwegian surveillance systems for infectious diseases.
Files
20241015_U4S - WP3 Pilot (Norway) - the value legal and technical aspects of relevant data sources investigated.pdf
Files
(866.1 kB)
Name | Size | Download all |
---|---|---|
md5:b06f2f068e8cd93d1ff74b92666c7865
|
866.1 kB | Preview Download |
Additional details
Identifiers
Dates
- Created
-
2024-10-15Surveillance of hospital admissions with respiratory tract infections in Norway